Staging pelvic lymphadenectomy for carcinoma of the prostate risk versus benefit.


Journal Article

A total of 125 patients underwent limited staging lymphadenectomy for adenocarcinoma of the prostate. Of these patients 19 per cent with clinical stage B1 disease, 52 per cent with clinical stage B2 disease and 59 per cent with clinical stages C disease had positive nodes. There was 1 death secondary to myocardial infarction and postoperative complications occurred in 7.2 per cent of the 125 patients. Limited staging pelvic node dissection provides information regarding nodal dissection similar to that identified after more extensive dissection and it can be accomplished with little morbidity.

Full Text

Duke Authors

Cited Authors

  • Brendler, CB; Cleeve, LK; Anderson, EE; Paulson, DF

Published Date

  • December 1, 1980

Published In

Volume / Issue

  • 124 / 6

Start / End Page

  • 849 - 850

PubMed ID

  • 7441837

Pubmed Central ID

  • 7441837

International Standard Serial Number (ISSN)

  • 0022-5347

Digital Object Identifier (DOI)

  • 10.1016/s0022-5347(17)55696-7


  • eng

Conference Location

  • United States